SPC

Slate Path Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History

Slate Path Capital’s Portfolio ALNY Stock Details ALNY Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-213,000	Closed	-$31M	–	30
2020 Q3	$31M	Sell	213,000 -371,000	-64%	-$54M	1.76%	16
2020 Q2	$86.5M	Sell	584,000 -134,000	-19%	-$19.8M	5.1%	11
2020 Q1	$78.2M	Sell	718,000 -97,000	-12%	-$10.6M	5.99%	6
2019 Q4	$93.9M	Buy	815,000 +200,000	+33%	+$23M	5.06%	9
2019 Q3	$49.5M	Hold	615,000	–	–	3.27%	11
2019 Q2	$44.6M	Buy	615,000 +135,000	+28%	+$9.8M	2%	11
2019 Q1	$44.9M	Hold	480,000	–	–	3.63%	10
2018 Q4	$35M	Hold	480,000	–	–	3.94%	11
2018 Q3	$42M	Hold	480,000	–	–	5.64%	9
2018 Q2	$47.3M	Buy	480,000 +105,000	+28%	+$10.3M	3.57%	11
2018 Q1	$44.7M	Sell	375,000 -72,000	-16%	-$8.58M	2.85%	13
2017 Q4	$56.8M	Sell	447,000 -114,000	-20%	-$14.5M	5.59%	7
2017 Q3	$65.9M	Sell	561,000 -574,000	-51%	-$67.4M	3.47%	12
2017 Q2	$90.5M	Sell	1,135,000 -865,000	-43%	-$69M	3.44%	9
2017 Q1	$103M	Hold	2,000,000	–	–	5.02%	11
2016 Q4	$74.9M	Buy	2,000,000 +775,000	+63%	+$29M	2.28%	10
2016 Q3	$83M	Buy	1,225,000 +90,000	+8%	+$6.1M	1.38%	5
2016 Q2	$63M	Hold	1,135,000	–	–	4.93%	10
2016 Q1	$71.2M	Buy	1,135,000 +410,000	+57%	+$25.7M	5.53%	7
2015 Q4	$68.3M	Buy	725,000 +130,000	+22%	+$12.2M	7.38%	7
2015 Q3	$47.8M	Sell	595,000 -86,759	-13%	-$6.97M	5.48%	6
2015 Q2	$81.7M	Sell	681,759 -173,241	-20%	-$20.8M	8.93%	8
2015 Q1	$89.3M	Hold	855,000	–	–	5.63%	9
2014 Q4	$82.9M	Hold	855,000	–	–	5.8%	8
2014 Q3	$66.8M	Buy	855,000 +257,000	+43%	+$20.1M	3%	9
2014 Q2	$37.8M	Buy	598,000 +186,460	+45%	+$11.8M	1.06%	13
2014 Q1	$27.6M	Sell	411,540 -588,460	-59%	-$39.5M	2.09%	13
2013 Q4	$64.3M	Sell	1,000,000 -260,000	-21%	-$16.7M	2.22%	14
2013 Q3	$80.7M	Buy	1,260,000 +210,000	+20%	+$13.4M	4.2%	12
2013 Q2	$32.6M	Buy	+1,050,000	New	+$32.6M	1.76%	12